Infectobicillin Saft (Phenoxymethylpenicillin Benzathine)

Phenoxymethylpenicillin benzathine, as Infectobicillin Saft, is indicated for bacterial infections caused by susceptible Gram‑positive organisms.

• Streptococcal pharyngitis: eliminates the causative Streptococcus pyogenes and shortens symptom duration.
• Acute otitis media: treats middle‑ear infection caused by penicillin‑sensitive bacteria.
• Skin and soft‑tissue infections: resolves cellulitis or impetigo due to susceptible organisms.
• Respiratory tract infections: manages community‑acquired pneumonia or bronchitis when the pathogen is penicillin‑sensitive.

• Phenoxymethylpenicillin benzathine exerts its antibacterial effect by binding to penicillin‑binding proteins (PBPs) located on the bacterial cell wall. This binding inhibits the transpeptidation step of peptidoglycan synthesis, weakening the wall and leading to osmotic lysis of susceptible Gram‑positive bacteria. The benzathine ester provides a prolonged release after oral administration, maintaining therapeutic concentrations over an extended period.

Phenoxymethylpenicillin benzathine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild stomach upset occurring in some patients.
• Diarrhea: loose stools, often self‑limiting.
• Rash: mild skin erythema or itching.
• Vaginal candidiasis: overgrowth of yeast causing discharge.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction with airway compromise.
• Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement.
• Clostridioides difficile colitis: severe intestinal inflammation following disruption of normal flora.

Before prescribing Phenoxymethylpenicillin benzathine, clinicians should consider several safety and handling precautions.

• Allergy assessment: verify no known hypersensitivity to penicillins or β‑lactam antibiotics.
• Renal function: adjust dosing in patients with impaired kidney function.
• Pregnancy and lactation: use only if clearly needed, as safety data are limited.
• Concomitant medications: review for potential interactions that may increase toxicity.
• Monitoring: observe for signs of severe allergic reactions during initial therapy.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Phenoxymethylpenicillin benzathine can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Oral contraceptives: may reduce hormonal effectiveness, increasing risk of unintended pregnancy.
• Methotrexate: concurrent use can heighten methotrexate toxicity, especially in high doses.
• Allopurinol: combined therapy raises the likelihood of severe skin reactions.

Moderate Interactions (Monitor Closely)

• NSAIDs: may increase risk of rash or gastrointestinal upset.
• Tetracyclines: bacteriostatic effect can antagonize the bactericidal action of penicillin.
• Warfarin: penicillin may alter INR, requiring closer coagulation monitoring.